<GlossaryTerm id="CDR0000793213"><TermName>Aranesp</TermName><TermPronunciation>(AYR-uh-nesp)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat anemia caused by chronic kidney disease and some types of chemotherapy. Aranesp is a form of erythropoietin (a substance naturally made by the kidneys) that is made in the laboratory. It helps the bone marrow make more red blood cells. Aranesp is a type of antianemic and a type of erythropoiesis-stimulating agent. Also called darbepoetin alfa.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000793665" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Aranesp&quot;" language="en" id="_3"/><MediaLink ref="CDR0000793664" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Aranesp&quot;" language="es" id="_4"/><SpanishTermName>Aranesp</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar la anemia causada por la enfermedad renal crónica y algunos tipos de quimioterapia. Aranesp es una forma de la eritropoyetina (sustancia que los riñones elaboran de forma natural) que se produce en el laboratorio. Ayuda a la médula ósea a producir más glóbulos rojos. Aranesp es un tipo de antianémico y de estimulante de la eritropoyesis. También se llama darbepoetina alfa.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2018-05-08</DateFirstPublished><DateLastModified>2018-05-08</DateLastModified><RelatedInformation><RelatedDrugSummaryRef UseWith="en" href="CDR0000793172" url="/about-cancer/treatment/drugs/darbepoetinalfa">Darbepoetin Alfa</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
